Clin2
NCT05429970Possibly a fitRecruiting

Reducing stress before ovarian cancer surgery with two medicines

Ovarian CancerOvarian CarcinomaStage II Ovary CancerStage II Ovarian CancerStage III Ovary CancerStage III Ovarian CancerStage IV Ovary CancerStage IV Ovarian Cancer

Treatments studied

Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.

This study tests whether giving two commonly used medicines before surgery—one that can lower stress on the body (a beta-blocker) and one that reduces inflammation (a COX-2 inhibitor)—can improve outcomes compared with standard care. It’s for people with advanced ovarian, fallopian tube, or primary peritoneal cancer who are having open surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
35 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have advanced (stage II–IV) ovarian, fallopian tube, or primary peritoneal cancer
  • You are scheduled for open abdominal surgery (exploratory laparotomy) and either PDS or IDS
  • Your surgery is at least 10 days away, so you can start the study medicines 7 days before surgery
  • You’re age 18 or older and able to consent and follow the study plan
  • You have no long-term use of beta-blockers or COX inhibitors

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06290193Recruiting· Phase 2
Blood thinning before surgery for ovarian cancer

This trial tests if removing some blood before surgery and replacing it with fluids can reduce the need for transfusions in people with advanced ovarian cancer. It may help you have less blood loss during your operation.

Basking Ridge, New Jersey
NCT06839144Recruiting· Phase 2
Medications before surgery to slow ovarian cancer growth

This trial tests whether giving two common medications before and after surgery can slow the growth of ovarian cancer. The medications may help reduce stress signals that could make cancer spread faster during surgery.

Ramat Gan
NCT07125391Recruiting· Phase 2
Chemo plus propranolol before surgery for advanced ovarian cancer

This trial tests adding propranolol (a heart medication) to standard chemotherapy before surgery for advanced high-grade serous ovarian cancer. The goal is to see if this combination helps shrink tumors more effectively.

Hefei, Anhui
NCT05364879Recruiting
Exercise before ovarian cancer surgery

This trial tests whether supervised exercise (before surgery) can help people with advanced ovarian cancer get ready for treatment. It’s meant to improve readiness and safety during the time leading up to surgery.

Halifax, Nova Scotia
NCT07609082Not yet recruiting
Exercise and nutrition before ovarian cancer surgery

This trial tests whether patients preparing for ovarian cancer surgery can safely use an exercise and nutrition program beforehand to improve strength and recovery. The study helps doctors understand the best way to deliver this type of preparation.

Kingston, Ontario
NCT06611072Recruiting
Boosting immune response in ovarian cancer surgery

This study examines how to improve the immune system's response during ovarian cancer surgery, potentially helping the body fight the cancer better. It compares patients with ovarian cancer to women having surgery for non-cancerous conditions.

Eindhoven, North Brabant

Hear when a new Ovarian cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.